Biogen Idec Owners | StatInvestor

Health Care & Life Sciences » Biotechnology | Biogen Idec Inc.

Biogen Idec Inc. | Ownership

Companies that own Biogen Idec Inc.

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

The Vanguard Group, Inc.

14,976,337

7.44%

185,973

0.17%

06/30/2018

PRIMECAP Management Co.

14,921,936

7.41%

-31,295

3.57%

06/30/2018

BlackRock Fund Advisors

11,438,579

5.68%

-636,874

0.2%

06/30/2018

ClearBridge Investments LLC

9,529,087

4.73%

340,828

2.89%

06/30/2018

SSgA Funds Management, Inc.

8,900,550

4.42%

154,494

0.24%

06/30/2018

Fidelity Management & Research Co.

5,111,447

2.54%

-1,341,028

0.18%

06/30/2018

Wellington Management Co. LLP

5,060,130

2.5%

-13,675

0.34%

06/30/2018

AllianceBernstein LP

3,831,425

1.9%

-193,345

0.78%

06/30/2018

Northern Trust Investments, Inc.

2,906,614

1.44%

33,785

0.23%

06/30/2018

AQR Capital Management LLC

2,840,495

1.41%

396,445

0.88%

06/30/2018

About Biogen Idec

View Profile

Address	225 Binney Street Cambridge Massachusetts 02142 United States
Employees	-
Website	http://www.biogen.com
Updated	07/08/2019
Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. It offers TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, ZINBRYTA, and FAMPYRA for the treatment of multiple sclerosis; SPINRAZA for the treatment of spinal muscular atrophy; and FUMADERM for the treatment of severe plaque psoriasis. The company was founded by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.